Find Penicillamine manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

REF. STANDARDS OR IMPURITIES

0

USP

0

JP

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

32RELATED EXCIPIENT COMPANIES

42EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

MARKET PLACE

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: D-penicillamine, 52-67-5, Cuprimine, D-(-)-penicillamine, 3-mercapto-d-valine, Depen
Molecular Formula
C5H11NO2S
Molecular Weight
149.21  g/mol
InChI Key
VVNCNSJFMMFHPL-VKHMYHEASA-N
FDA UNII
GNN1DV99GX

Penicillamine
3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
Penicillamine is an Antirheumatic Agent.
1 2D Structure

Penicillamine

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2S)-2-amino-3-methyl-3-sulfanylbutanoic acid
2.1.2 InChI
InChI=1S/C5H11NO2S/c1-5(2,9)3(6)4(7)8/h3,9H,6H2,1-2H3,(H,7,8)/t3-/m0/s1
2.1.3 InChI Key
VVNCNSJFMMFHPL-VKHMYHEASA-N
2.1.4 Canonical SMILES
CC(C)(C(C(=O)O)N)S
2.1.5 Isomeric SMILES
CC(C)([C@H](C(=O)O)N)S
2.2 Other Identifiers
2.2.1 UNII
GNN1DV99GX
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Beta,beta Dimethylcysteine

2. Beta,beta-dimethylcysteine

3. Copper Penicillaminate

4. Cuprenil

5. Cuprimine

6. D 3 Mercaptovaline

7. D Penicillamine

8. D-3-mercaptovaline

9. D-penicillamine

10. Dimethylcysteine

11. Mercaptovaline

12. Metalcaptase

13. Penicillaminate, Copper

2.3.2 Depositor-Supplied Synonyms

1. D-penicillamine

2. 52-67-5

3. Cuprimine

4. D-(-)-penicillamine

5. 3-mercapto-d-valine

6. Depen

7. Cuprenil

8. D-penamine

9. (-)-penicillamine

10. Artamine

11. (2s)-2-amino-3-methyl-3-sulfanylbutanoic Acid

12. D-valine, 3-mercapto-

13. Kuprenil

14. Mercaptyl

15. Perdolat

16. Trolovol

17. D-3-mercaptovaline

18. (s)-3,3-dimethylcysteine

19. Penicilamina

20. Penicillaminum

21. 3-sulfanyl-d-valine

22. D-beta,beta-dimethylcysteine

23. D-mercaptovaline

24. Penicillamin

25. Beta-thiovaline

26. Metalcaptase

27. (d)-penicillamine

28. Beta,beta-dimethylcysteine

29. D-penicilamine

30. (s)-2-amino-3-mercapto-3-methylbutanoic Acid

31. Penicillamina [dcit]

32. Distamine

33. Penicilamina [inn-spanish]

34. Penicillaminum [inn-latin]

35. Cupripen

36. Depamine

37. Pendramine

38. Chebi:7959

39. (s)-penicillamine

40. Penicillamine (cuprimine)

41. Reduced Penicillamine

42. Sufirtan

43. Gnn1dv99gx

44. Chembl1430

45. Reduced D-penicillamine

46. 3,3-dimethyl-d-cysteine

47. Nsc-81549

48. (s)-penicillamin

49. D,3-mercaptovaline

50. Ncgc00024359-04

51. Penicillamina

52. Mfcd00064302

53. Sufortan

54. Cuprimine (tn)

55. Valine, 3-mercapto-, D-

56. Ccris 2904

57. D-beta-mercaptovaline

58. Depen (tn)

59. Hsdb 3378

60. Sr-01000000262

61. Einecs 200-148-8

62. Unii-gnn1dv99gx

63. Nsc 81549

64. Alpha-amino-beta-methyl-beta-mercaptobutyric Acid

65. (2s)-2-amino-3-methyl-3-sulfanyl-butanoic Acid

66. Distamine (*hydrochloride*)

67. D-penicillamin

68. Penicillamine (jan/usp/inn)

69. Dimethyl Cysteine

70. Metalcaptase (*hydrochloride*)

71. Penicillamine-(d)

72. 3-thio-d-valine

73. Penicillamine,(s)

74. D-(-)-2-amino-3-mercapto-3-methylbutanoic Acid

75. Nsc81549

76. Penicillamine-(racemic)

77. Spectrum_000283

78. Penicillamine [usan:usp:inn:ban:jan]

79. Spectrum2_001029

80. Spectrum3_000541

81. Spectrum4_000470

82. Spectrum5_001196

83. Penicillamine [mi]

84. Epitope Id:113237

85. P-1280

86. Penicillamine [inn]

87. Penicillamine [jan]

88. Schembl4343

89. Dsstox_cid_17069

90. Dsstox_rid_79300

91. Penicillamine [hsdb]

92. Penicillamine [usan]

93. Dsstox_gsid_37069

94. Bspbio_002181

95. Kbiogr_000920

96. Kbioss_000763

97. Penicillamine [vandf]

98. Cid_92173

99. Divk1c_000314

100. Penicillamine [mart.]

101. Spbio_001217

102. D-penicillamine, 98-101%

103. Penicillamine [usp-rs]

104. Penicillamine [who-dd]

105. Gtpl7264

106. Dtxsid6037069

107. Bdbm39346

108. Kbio1_000314

109. Kbio2_000763

110. Kbio2_003331

111. Kbio2_005899

112. Kbio3_001681

113. Ninds_000314

114. Zinc114127

115. Penicillamine [ep Impurity]

116. Penicillamine [orange Book]

117. Bcp17247

118. Hy-b0300

119. Str02534

120. Penicillamine [ep Monograph]

121. Tox21_110899

122. Bdbm50217941

123. Penicillamine [usp Monograph]

124. S1853

125. Akos006237201

126. Zinc100509167

127. Am83710

128. Ccg-266197

129. Db00859

130. Cas-52-67-5

131. Idi1_000314

132. Smp1_000042

133. Ncgc00018283-01

134. Ncgc00024359-05

135. Ncgc00024359-06

136. P0147

137. En300-52608

138. C07418

139. D00496

140. M06142

141. P15236

142. 064p302

143. Q421239

144. Sr-01000000262-3

145. Sr-01000000262-4

146. (2s)-2-amino-3-mercapto-3-methyl-butyric Acid;hydrochloride

147. (2s)-2-amino-3-mercapto-3-methylbutanoic Acid;hydrochloride

148. (2s)-2-azanyl-3-methyl-3-sulfanyl-butanoic Acid;hydrochloride

149. Penicillamine, European Pharmacopoeia (ep) Reference Standard

150. (2s)-2-amino-3-methyl-3-sulfanylbutanoic Acid3-sulfanyl-d-valine

151. Penicillamine, United States Pharmacopeia (usp) Reference Standard

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 149.21 g/mol
Molecular Formula C5H11NO2S
XLogP3-1.8
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count4
Rotatable Bond Count2
Exact Mass149.05104977 g/mol
Monoisotopic Mass149.05104977 g/mol
Topological Polar Surface Area64.3 Ų
Heavy Atom Count9
Formal Charge0
Complexity124
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Information
1 of 4  
Drug NameCuprimine
PubMed HealthPenicillamine (By mouth)
Drug ClassesAntirheumatic, Heavy Metal Chelator, Renal-Urologic Agent
Drug LabelPenicillamine is a chelating agent used in the treatment of Wilson's disease. It is also used to reduce cystine excretion in cystinuria and to treat patients with severe, active rheumatoid arthritis unresponsive to conventional therapy (see INDICATIO
Active IngredientPenicillamine
Dosage FormCapsule
RouteOral
Strength250mg
Market StatusPrescription
CompanyAton

2 of 4  
Drug NameDepen
PubMed HealthPenicillamine (By mouth)
Drug ClassesAntirheumatic, Heavy Metal Chelator, Renal-Urologic Agent
Drug LabelDESCRIPTION - Penicillamine is 3-mercapto-D-valine, a disease modifying antirheumatic drug. It is a white or practically white, crystalline powder, freely soluble in water, slightly soluble in alcohol, and insoluble in ether, acetone, benzene, and ca...
Active IngredientPenicillamine
Dosage FormTablet
RouteOral
Strength250mg
Market StatusPrescription
CompanyMeda Pharms

3 of 4  
Drug NameCuprimine
PubMed HealthPenicillamine (By mouth)
Drug ClassesAntirheumatic, Heavy Metal Chelator, Renal-Urologic Agent
Drug LabelPenicillamine is a chelating agent used in the treatment of Wilson's disease. It is also used to reduce cystine excretion in cystinuria and to treat patients with severe, active rheumatoid arthritis unresponsive to conventional therapy (see INDICATIO
Active IngredientPenicillamine
Dosage FormCapsule
RouteOral
Strength250mg
Market StatusPrescription
CompanyAton

4 of 4  
Drug NameDepen
PubMed HealthPenicillamine (By mouth)
Drug ClassesAntirheumatic, Heavy Metal Chelator, Renal-Urologic Agent
Drug LabelDESCRIPTION - Penicillamine is 3-mercapto-D-valine, a disease modifying antirheumatic drug. It is a white or practically white, crystalline powder, freely soluble in water, slightly soluble in alcohol, and insoluble in ether, acetone, benzene, and ca...
Active IngredientPenicillamine
Dosage FormTablet
RouteOral
Strength250mg
Market StatusPrescription
CompanyMeda Pharms

4.2 Therapeutic Uses

Antidotes; Antirheumatic Agents; Chelating Agents

National Library of Medicine's Medical Subject Headings online file (MeSH, 1999)


THE D ISOMER IS USED CLINICALLY, ALTHOUGH THE L ISOMER ALSO FORMS CHELATION COMPLEXES. PENICILLAMINE IS EFFECTIVE CHELATOR OF COPPER, MERCURY, ZINC, & LEAD & PROMOTES EXCRETION OF THESE METALS IN URINE.

Gilman, A.G., T.W. Rall, A.S. Nies and P. Taylor (eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 8th ed. New York, NY. Pergamon Press, 1990., p. 1610


THERE IS SOME PROMISE IN TREATMENT OF RHEUMATOID ARTHRITIS WITH PENICILLAMINE. ... BENEFICIAL EFFECT IS SEEN ONLY AFTER SEVERAL WK OF TREATMENT, & ARTHRITIC SYMPTOMS RETURN IF DRUG IS WITHDRAWN PREMATURELY.

Goodman, L.S., and A. Gilman. (eds.) The Pharmacological Basis of Therapeutics. 5th ed. New York: Macmillan Publishing Co., Inc., 1975., p. 920


PENICILLAMINE HAS BECOME ESTABLISHED IN TREATMENT OF CYSTINURIA & ASSOC NEPHROLITHIASIS. IN DOSE OF 30 MG/KG/DAY, IT LOWERS OR ELIMINATES URINARY CYSTINE & PREVENTS FURTHER STONE DEVELOPMENT.

Goodman, L.S., and A. Gilman. (eds.) The Pharmacological Basis of Therapeutics. 5th ed. New York: Macmillan Publishing Co., Inc., 1975., p. 920


For more Therapeutic Uses (Complete) data for (D)-PENICILLAMINE (11 total), please visit the HSDB record page.


4.3 Drug Warning

VET: USE IN PREGNANCY IS CONTRAINDICATED BECAUSE OF ITS CHELATING EFFECT ON TRACE METALS.

Rossoff, I.S. Handbook of Veterinary Drugs. New York: Springer Publishing Company, 1974., p. 417


CROSS SENSITIVITY BETWEEN PENICILLIN & PENICILLAMINE DOES NOT ALWAYS OCCUR; THEREFORE, PENICILLAMINE CAN BE GIVEN CAUTIOUSLY TO PATIENTS WHO ARE HYPERSENSITIVE TO PENICILLIN.

American Medical Association. AMA Drug Evaluations Annual 1991. Chicago, IL: American Medical Association, 1991., p. 757


CAREFUL EXAM OF SKIN, AS WELL AS URINALYSIS, DIFFERENTIAL & WHITE BLOOD CELL COUNTS, DIRECT PLATELET COUNTS, & HEMOGLOBIN DETERMINATION SHOULD BE PERFORMED.

American Medical Association. AMA Drug Evaluations Annual 1991. Chicago, IL: American Medical Association, 1991., p. 757


EXPTL, TOXIC EFFECTS IN RATS GIVEN HIGH DOSES OF PENICILLAMINE RESEMBLE THOSE SEEN IN PYRIDOXINE DEFICIENCY, & EFFECTS ARE REVERSED BY FEEDING PYRIDOXINE. IN HUMAN BEINGS, PYRIDOXINE ANTAGONISM IS READILY DEMONSTRATED WITH L & DL FORMS, BUT RARELY WITH D FORM. ... INCR URINARY EXCRETION OF XANTHURENIC ACID & KYNURENINE.

Goodman, L.S., and A. Gilman. (eds.) The Pharmacological Basis of Therapeutics. 5th ed. New York: Macmillan Publishing Co., Inc., 1975., p. 919


For more Drug Warnings (Complete) data for (D)-PENICILLAMINE (11 total), please visit the HSDB record page.


4.4 Drug Indication

For treatment of Wilson's disease, cystinuria and active rheumatoid arthritis.


FDA Label


5 Pharmacology and Biochemistry
5.1 Pharmacology

Penicillamine is a chelating agent used in the treatment of Wilson's disease. It is also used to reduce cystine excretion in cystinuria and to treat patients with severe, active rheumatoid arthritis unresponsive to conventional therapy. Penicillamine is used as a form of immunosuppression to treat rheumatoid arthritis. Penicillamine inhibits macrophages, decreases IL-1 and the number of T-lymphocytes, and prevents collagen cross linkage. In Wilson's disease it binds copper, allowing it to be eliminated in the urine.


5.2 MeSH Pharmacological Classification

Antidotes

Agents counteracting or neutralizing the action of POISONS. (See all compounds classified as Antidotes.)


Chelating Agents

Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. (See all compounds classified as Chelating Agents.)


Antirheumatic Agents

Drugs that are used to treat RHEUMATOID ARTHRITIS. (See all compounds classified as Antirheumatic Agents.)


5.3 FDA Pharmacological Classification
5.3.1 Active Moiety
PENICILLAMINE
5.3.2 FDA UNII
GNN1DV99GX
5.3.3 Pharmacological Classes
Antirheumatic Agent [EPC]
5.4 ATC Code

M - Musculo-skeletal system

M01 - Antiinflammatory and antirheumatic products

M01C - Specific antirheumatic agents

M01CC - Penicillamine and similar agents

M01CC01 - Penicillamine


5.5 Absorption, Distribution and Excretion

Absorption

rapidly but incompletely


Route of Elimination

Excretion is mainly renal, mainly as disulfides.


HUMAN SUBJECTS SUFFERING FROM WILSON'S DISEASE, RAPIDLY ABSORBED ORAL DOSE OF (35)S DL-PENICILLAMINE. PLASMA CONCN OF (35)S PEAKED WITHIN 60 MIN. (35)S WAS RAPIDLY EXCRETED, ALMOST COMPLETELY IN 24 HR URINE WHERE 73% OF ADMIN (35)S ... RECOVERED. THERE WAS INTERSUBJECT VARIATION IN EXTENT OF BINDING ... BY PLASMA PROTEINS. /DL-PENICILLAMINE/

The Chemical Society. Foreign Compound Metabolism in Mammals. Volume 2: A Review of the Literature Published Between 1970 and 1971. London: The Chemical Society, 1972., p. 135


FROM METABOLIC POINT OF VIEW, D-PENICILLAMINE IS VIRTUALLY INERT, & THIS OBSERVATION IS COMPATIBLE WITH FACT THAT EXTRACELLULAR WATER MAKES UP MAIN DISTRIBUTION VOL FOR D-PENICILLAMINE.

The Chemical Society. Foreign Compound Metabolism in Mammals. Volume 4: A Review of the Literature Published during 1974 and 1975. London: The Chemical Society, 1977., p. 153


PENICILLAMINE IS WELL ABSORBED (40% to70%) FROM GI TRACT &, THEREFORE, HAS DECIDED ADVANTAGE OVER OTHER CHELATING AGENTS. PEAK CONCN IN BLOOD ARE OBTAINED BETWEEN 1 AND 3 HR AFTER ADMINISTRATION. ... /IT/ IS SOMEWHAT RESISTANT TO ATTACK BY CYSTEINE DESULFHYDRASE OR L-AMINO ACID OXIDASE. AS A RESULT ... IS RELATIVELY STABLE IN VIVO. ... HEPATIC BIOTRANSFORMATION IS RESPONSIBLE FOR MOST OF THE DEGRADATION OF PENICILLAMINE, AND VERY LITTLE IS EXCRETED UNCHANGED. METABOLITES ARE FOUND IN BOTH URINE AND FECES.

Gilman, A.G., T.W. Rall, A.S. Nies and P. Taylor (eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 8th ed. New York, NY. Pergamon Press, 1990., p. 1610


The effects of chelating agents (citric acid, tartaric acid, penicillamine and ethylenediaminetetraacetic acid) and cysteine on the absorption of mercuric chloride were investigated in rats. Perfusion of the small intestine showed that the chelating agents and cysteine decreased the absorption of mercuric chloride depending on their stability of constants wtih Hg2+, under the predominant conditions of water absorption and secretion. The difference in absorption of mercuric chloride between both conditions was inversely correlated with their logarithmic stability constant values. These agents decreased the transport of mercuric chloride through the everted intestinal wall and the uptake of mercuric chloride by the intestinal brush border membrane in a similar manner. From these results, it is suggested that the chelating agents and cysteine decrease the absorption of mercuric chloride through the pores of the brush border membrane due to th solvent drag effect.

PMID:2057447 Endo T et al; Pharmacol Toxicol 68 (3): 171-6 (1991)


For more Absorption, Distribution and Excretion (Complete) data for (D)-PENICILLAMINE (7 total), please visit the HSDB record page.


5.6 Metabolism/Metabolites

Hepatic


The transformation of D-penicillamine was studied in orally and iv dosed rats and in human plasma in vitro. In each case, low molecular weight metabolites (previously identified as disulfides) and a mixed disulfide between D-penicillamine and albumin (D-penicillamine-protein) formed. The rates of D-penicillamine elimination, other than through protein conjugation, were comparable in the rat groups to the rate of oxidation to low molecula weight metabolites in vitro. The rates of transformation to D-penicillamine protein were also comparable in the in vitro preparations and in orally treated rats. These qualitative and quantitative similarities suggest blood plasma may be an important site of transformation in vivo. Extracellular oxidation of D-penicillamine may be linked to its antirheumatic action, either through reduction of oxygen species or through formation of D-penicillamine protein disulfides at surfaces of mononuclear leukocytes.

PMID:2085148 Joyce DA, Murphy BR; Agents Actions 31 (3-4): 353-7 (1990)


5.7 Biological Half-Life

1 hour


5.8 Mechanism of Action

Penicillamine is a chelating agent recommended for the removal of excess copper in patients with Wilson's disease. From in vitro studies which indicate that one atom of copper combines with two molecules of penicillamine. Penicillamine also reduces excess cystine excretion in cystinuria. This is done, at least in part, by disulfide interchange between penicillamine and cystine, resulting in formation of penicillamine-cysteine disulfide, a substance that is much more soluble than cystine and is excreted readily. Penicillamine interferes with the formation of cross-links between tropocollagen molecules and cleaves them when newly formed. The mechanism of action of penicillamine in rheumatoid arthritis is unknown although it appears to suppress disease activity. Unlike cytotoxic immunosuppressants, penicillamine markedly lowers IgM rheumatoid factor but produces no significant depression in absolute levels of serum immunoglobulins. Also unlike cytotoxic immunosuppressants which act on both, penicillamine in vitro depresses T-cell activity but not B-cell activity.


The rationale for ... use in cyctinuria is that penicillamine forms a relatively soluble disulfide compound with cysteine through a disulfide interchange mechanism and thereby decr the formation of cystine containing renal stones.

Gilman, A.G., T.W. Rall, A.S. Nies and P. Taylor (eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 8th ed. New York, NY. Pergamon Press, 1990., p. 1610


Penicillamine chelates mercury, lead, copper, iron, and probably other heavy metals to form stable, soluble complexes that are readily excreted in the urine.

US Pharmacopeial Convention; US Pharmacopeia Dispensing Information (USP DI); Drug Information for the Health Care Professional 12th ed, V.I p.2158 (1992)


The mechanism of action of penicillamine in rheumatoid arthritis is not known, but may involve improvement of lymphocyte function. It markedly reduces IgM rheumatoid factor and immune complexes in serum and synovial fluid, but does not significantly lower absolute concentrations of serum immunoglobulins. In vitro, penicillamine depresses T-cell but not B-cell activity. However, the relationship of these effects to the activity of penicillamine in rheumatoid arthritis is not known.

US Pharmacopeial Convention; US Pharmacopeia Dispensing Information (USP DI); Drug Information for the Health Care Professional 12th ed, V.I p.2158 (1992)


Antiurolithic (cystine calculi) Penicillamine combines chemically with cystine (cysteine-cysteine disulfide) to form penicillamine cysteine disulfide, which is more soluble than cystine and is readily excreted. As a result, urinary cystine concentrations are lowered and the formation of cystine calculi is prevented. With prolonged treatment, existing cystine calculi may be gradually dissolved.

US Pharmacopeial Convention; US Pharmacopeia Dispensing Information (USP DI); Drug Information for the Health Care Professional 12th ed, V.I p.2158 (1992)


USDMF

read-more
read-moreread-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBiophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Flag India
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2017-01-13

Pay. Date : 2016-09-28

DMF Number : 30833

Submission : 2016-09-28

Status : Active

Type : II

Biophore

02

Vietnam Medi-Pharm Expo
Not Confirmed

02

Vietnam Medi-Pharm Expo
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 23156

Submission : 2009-09-25

Status : Inactive

Type : II

blank

03

Vietnam Medi-Pharm Expo
Not Confirmed

03

Vietnam Medi-Pharm Expo
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 24013

Submission : 2010-07-30

Status : Active

Type : II

blank

04

Laborchemie Apolda Gmbh

Germany

USDMF

arrow
Vietnam Medi-Pharm Expo
Not Confirmed

04

Vietnam Medi-Pharm Expo
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 26681

Submission : 2012-11-15

Status : Active

Type : II

blank

05

Sigma F And D Div Ltd

U.S.A

USDMF

arrow
Vietnam Medi-Pharm Expo
Not Confirmed

05

Vietnam Medi-Pharm Expo
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 7690

Submission : 1988-09-21

Status : Inactive

Type : II

blank

06

Wanbury Ltd

India

USDMF

arrow
Vietnam Medi-Pharm Expo
Not Confirmed

06

Wanbury Ltd

India
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 24701

Submission : 2011-03-01

Status : Inactive

Type : II

blank

07

Biogal Pharmaceutical Works

Country

USDMF

arrow
Vietnam Medi-Pharm Expo
Not Confirmed

07

Biogal Pharmaceutical Works

Country
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 5413

Submission : 1984-05-09

Status : Inactive

Type : II

blank

08

Biochemie Deutschland Gmbh

Country

USDMF

arrow
Vietnam Medi-Pharm Expo
Not Confirmed

08

Biochemie Deutschland Gmbh

Country
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 13601

Submission : 1998-09-01

Status : Inactive

Type : II

blank

09

Biochemic Gesellschaft Mbh

Country

USDMF

arrow
Vietnam Medi-Pharm Expo
Not Confirmed

09

Biochemic Gesellschaft Mbh

Country
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 5521

Submission : 1984-08-16

Status : Inactive

Type : II

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EU WC

read-more
read-moreread-more

01

Vietnam Medi-Pharm Expo
Not Confirmed
arrow
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

Penicillamine USP

Date of Issue : 2024-05-07

Valid Till : 2027-04-02

Written Confirmation Number : WC-491n

Address of the Firm : Plot No. 152 & 160, Phase-V, IDA Jeedimetla, Hyderabad., Jeedimetla (V), Quthbul...

blank

02

Vietnam Medi-Pharm Expo
Not Confirmed
arrow
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

D-Penicillamine Ph.Eur

Date of Issue : 2024-05-07

Valid Till : 2027-04-02

Written Confirmation Number : WC-491n

Address of the Firm : Plot No. 152 & 160, Phase-V, IDA Jeedimetla, Hyderabad., Jeedimetla (V), Quthbul...

blank

03

Vietnam Medi-Pharm Expo
Not Confirmed
arrow
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

D-Penicillamine Ph.Eur.

Date of Issue : 2022-09-30

Valid Till : 2024-02-04

Written Confirmation Number : WC-0491A3

Address of the Firm : Plot No.152&160, Phase-V, IDA Jeedimetla, Hyderabad., Jeedimetla(V), Quthbullapu...

blank

04

Vietnam Medi-Pharm Expo
Not Confirmed
arrow
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

Penicillamine USP/EP

Date of Issue : 2026-03-16

Valid Till : 2029-03-15

Written Confirmation Number : WC-0457

Address of the Firm : Sy No 544, 545 & 546, Bhiknoor (V), Bhiknoor (M), Kamareddy-503101, Telangana, I...

blank

05

Vietnam Medi-Pharm Expo
Not Confirmed
arrow
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

D-Penicillamine IH/USP

Date of Issue : 2025-09-12

Valid Till : 2028-07-02

Written Confirmation Number : WC-0182

Address of the Firm : Unit I, Survey No. 239 & 240, Dothigudem (V), Pochampally (M), Yadadri Bhuvanagi...

blank

06

Vietnam Medi-Pharm Expo
Not Confirmed
arrow
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

D-Pencillamine IH/USP

Date of Issue : 2023-11-15

Valid Till : 2026-05-11

Written Confirmation Number : WC-0273

Address of the Firm : Plot No: 34A, Road No: 1, Jawaharlal Nehru Pharma City, Thanam Village, Parawada...

blank

07

Vietnam Medi-Pharm Expo
Not Confirmed
arrow
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

Penicillamine USP/IH

Date of Issue : 2022-08-16

Valid Till : 2025-07-15

Written Confirmation Number : WC-0042N

Address of the Firm : Plot Nos. 262 to 271, IDA, Pashamylaram, Sangareddy District- 502 307, Telangana...

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBiophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Flag India
Digital Content Digital Content

Penicillamine

About the Company : Biophore, founded in 2007, develops and manufactures niche and complex pharmaceutical products. With USFDA- and EU-approved API facilities, a dedicated intermediates site and an R&...

Biophore, founded in 2007, develops and manufactures niche and complex pharmaceutical products. With USFDA- and EU-approved API facilities, a dedicated intermediates site and an R&D center of 400 scientists, the company is a leading global API player. Biophore ranks among the top US DMF filers, holds 150+ patents and maintains a strong compliance record with major regulatory agencies. Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
Biophore

02

HRV Pharma

India
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHRV Pharma - Market Expansion Leader in Pharmaceuticals.

Flag India
Digital Content Digital Content

Penicillamine

About the Company : HRV Pharma is a global manufacturer, seller, and exporter of APIs, intermediates, pellets, food-grade chemicals, food additives, and food ingredients. The company provides sourcing...

HRV Pharma is a global manufacturer, seller, and exporter of APIs, intermediates, pellets, food-grade chemicals, food additives, and food ingredients. The company provides sourcing, manufacturing, and supply services to support partners entering new markets worldwide. HRV Pharma works closely with major pharma and food additive companies and represents over 30 Indian drugmakers, primarily serving Europe, the US, and the Middle East. Headquartered in India, it operates offices in the US, Switzerland, Dubai, Lithuania, and Turkey. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
HRV Global Life Sciences

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothWillow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

Flag U.S.A
Digital Content Digital Content

Penicillamine

About the Company : Willow Birch Pharma, Inc. is a premier supplier of bulk APIs to North American Compounding Pharmacies, sourcing from FDA registered and GMP manufacturers. With licenses in all 50 s...

Willow Birch Pharma, Inc. is a premier supplier of bulk APIs to North American Compounding Pharmacies, sourcing from FDA registered and GMP manufacturers. With licenses in all 50 states as a drug wholesaler and NABP accreditation since 2007, Willow Birch Pharma delivers top-quality products at competitive prices with unparalleled service and regulatory support nationwide. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Company Banner

04

Vietnam Medi-Pharm Expo
Not Confirmed
arrow
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

Penicillamine

About the Company : Fleming Laboratories Limited is in the business of manufacturing and supply of high-quality generic Active Pharmaceutical Ingredients (APIs) to the global Pharmaceutical Industry. ...

Fleming Laboratories Limited is in the business of manufacturing and supply of high-quality generic Active Pharmaceutical Ingredients (APIs) to the global Pharmaceutical Industry. The facilities are audited & approved by /accredited with various Regulatory agencies including EUGMP, EDQM, WHO GMP, PMDA (Japan), COFEPRIS (Mexico), Korea FDA.
blank

05

Vietnam Medi-Pharm Expo
Not Confirmed
arrow
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

D-Penicillamine

About the Company : Jiangxi Dongfeng Pharmaceutical Co., Ltd., which was established in 1965, as state-owned large scale pharmaceutical enterprise, is one of the earliest antibiotic production enterpr...

Jiangxi Dongfeng Pharmaceutical Co., Ltd., which was established in 1965, as state-owned large scale pharmaceutical enterprise, is one of the earliest antibiotic production enterprise in China , it is also one of major production base of antibiotic APIs and formulations in China. For more than forty yeas , the penicillin and cephalosporin series products with “JiangDong” brand manufactured by us have been the famous branded products in domestic and global markets with a good marketing, the company have presented glorious pages during the development history of Chinese antibiotics field.
blank

06

Vietnam Medi-Pharm Expo
Not Confirmed
arrow
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

Penicillamine

About the Company : Optimus is one of the fastest-growing pharmaceutical companies with 16 years of experience in providing the best quality of API, Intermediates & Finished formulations in Global mar...

Optimus is one of the fastest-growing pharmaceutical companies with 16 years of experience in providing the best quality of API, Intermediates & Finished formulations in Global markets. Our aim from day one has been to provide and ensure better healthcare across the globe through our research, Innovations, affordable products & manufacturing excellence. Optimus was established to provide quality & affordable pharmaceutical products in the global markets.
blank

07

Vietnam Medi-Pharm Expo
Not Confirmed
arrow
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

D-Penicillamine

About the Company : Prajna is an innovation driven pharmaceutical company. We dedicated to Research, Process development and Manufacturing APIs and Advanced Intermediates for Active Pharmaceutical Ing...

Prajna is an innovation driven pharmaceutical company. We dedicated to Research, Process development and Manufacturing APIs and Advanced Intermediates for Active Pharmaceutical Ingredients (APIs) for the global pharmaceutical companies. It provides value-added services in Contract Research, Custom Synthesis, and Specialties Scientific technology (Green Process, APIs Process Development, Polymorphism, Crystallisation and Purification) for Pharmaceutical and Life Sciences industry.
blank

08

Vietnam Medi-Pharm Expo
Not Confirmed
arrow
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

Penicillamine

About the Company : RR LIFESCIENCES manufactures products purely by organic synthesis to offer its customers a choice of products in their areas. Our facilities are equipped with a range of reactor si...

RR LIFESCIENCES manufactures products purely by organic synthesis to offer its customers a choice of products in their areas. Our facilities are equipped with a range of reactor sizes, glass lined reactors and S.S. Reactors, some reactors are capable of operating at high extreme temperature. Other equipments includes Centrifuges, Vacuum Tray Drier, Multi Mills, Tray Drier, in clean finishing suites. All Our facilities are GMP complaint, designed to maintain the highest standards of safety. Our R&D scale-up capabilities from lab scale to commercialization. Our team of experts interacts with our customers from the initial stages of the project to ensure successful completion of the project. We follow stringent quality assurance norms and it has the domain expertise and state of art of facilities to develop analytical methods for evaluating quality of raw materials, intermediates and final products. Our R&D scale-up capabilities from lab scale to commercialization. Our team of experts interacts with our customers from the initial stages of the project to ensure successful completion of the project. We follow stringent quality assurance norms and it has the domain expertise and state of art of facilities to develop analytical methods for evaluating quality of raw materials, intermediates and final products.
blank

09

Vietnam Medi-Pharm Expo
Not Confirmed
arrow
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

Penicillamine

About the Company : Sekhmet Pharmaventures Pvt. Ltd., an Indian subsidiary of Gamot API Pte. Ltd., is backed by prominent private equity firms including PAG, CX Partners, and Samara Capital. The compa...

Sekhmet Pharmaventures Pvt. Ltd., an Indian subsidiary of Gamot API Pte. Ltd., is backed by prominent private equity firms including PAG, CX Partners, and Samara Capital. The company has acquired majority stakes in Anjan Drug (2020) and Optimus Drugs (2022), and is investing in new manufacturing facilities focused on APIs and formulations. With this strategy, Sekhmet aims to become a leading integrated pharma platform, supporting India's growing role in the global supply chain.
blank

10

Vietnam Medi-Pharm Expo
Not Confirmed
arrow
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

Penicillamine

About the Company : Sionc pharmaceuticals is specialized in manufacturing of complex and niche Active Pharmaceutical Ingredients in various therapeutic categories. Sionc has evolved as a reliable cont...

Sionc pharmaceuticals is specialized in manufacturing of complex and niche Active Pharmaceutical Ingredients in various therapeutic categories. Sionc has evolved as a reliable contributor in the generic drug industry for Regulatory markets with customer-centric approach since its inception in 2010. To Emerge as a Leading Global Pharmaceutical Company which creates value for all customers by offering excellence in product Quality Standard with committed service and be a significant contributor for global markets.
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBiophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Flag India
Digital Content Digital Content

Regulatory Info :

Registration Country : India

Penicillamine

Brand Name :

Dosage Form : Capsule

Dosage Strength : 250MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Biophore

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content

Regulatory Info : RX

Registration Country : USA

PENICILLAMINE

Brand Name : PENICILLAMINE

Dosage Form : CAPSULE;ORAL

Dosage Strength : 250MG

Packaging :

Approval Date : 2020-08-04

Application Number : 211867

Regulatory Info : RX

Registration Country : USA

Dr Reddy Company Banner

03

PENICILLAMINE

Brand Name : PENICILLAMINE

Dosage Form : CAPSULE;ORAL

Dosage Strength : 250MG

Packaging :

Approval Date : 2021-08-23

Application Number : 215409

Regulatory Info : RX

Registration Country : USA

Breckenridge Pharmaceutical

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGranules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Flag India
Digital Content Digital Content

Regulatory Info : RX

Registration Country : USA

PENICILLAMINE

Brand Name : PENICILLAMINE

Dosage Form : CAPSULE;ORAL

Dosage Strength : 250MG

Packaging :

Approval Date : 2020-12-02

Application Number : 211735

Regulatory Info : RX

Registration Country : USA

Granules India

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGranules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Flag India
Digital Content Digital Content

Regulatory Info :

Registration Country : India

Penicillamine

Brand Name : Penicillamine

Dosage Form : Immediate Release Capsule

Dosage Strength : 250MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Granules India

06

Actavis Inc

Ireland
German Wound Congress
Not Confirmed
arrow

Actavis Inc

Ireland
arrow
German Wound Congress
Not Confirmed

PENICILLAMINE

Brand Name : PENICILLAMINE

Dosage Form : CAPSULE;ORAL

Dosage Strength : 250MG

Packaging :

Approval Date : 2019-06-24

Application Number : 210976

Regulatory Info : RX

Registration Country : USA

blank

07

German Wound Congress
Not Confirmed
arrow
arrow
German Wound Congress
Not Confirmed

PENICILLAMINE

Brand Name : LUXZYLA

Dosage Form : CAPSULE;ORAL

Dosage Strength : 250MG

Packaging :

Approval Date : 2019-05-07

Application Number : 209921

Regulatory Info : DISCN

Registration Country : USA

blank

08

Bausch Health

Canada
German Wound Congress
Not Confirmed
arrow

Bausch Health

Canada
arrow
German Wound Congress
Not Confirmed

PENICILLAMINE

Brand Name : CUPRIMINE

Dosage Form : CAPSULE;ORAL

Dosage Strength : 250MG

Packaging :

Approval Date : 1982-01-01

Application Number : 19853

Regulatory Info : RX

Registration Country : USA

blank

09

Bausch Health

Canada
German Wound Congress
Not Confirmed
arrow

Bausch Health

Canada
arrow
German Wound Congress
Not Confirmed

PENICILLAMINE

Brand Name : CUPRIMINE

Dosage Form : CAPSULE;ORAL

Dosage Strength : 125MG

Packaging :

Approval Date : 1982-01-01

Application Number : 19853

Regulatory Info : DISCN

Registration Country : USA

blank

10

Viatris

U.S.A
German Wound Congress
Not Confirmed
arrow

Viatris

U.S.A
arrow
German Wound Congress
Not Confirmed

PENICILLAMINE

Brand Name : DEPEN

Dosage Form : TABLET;ORAL

Dosage Strength : 250MG

Packaging :

Approval Date : 1982-01-01

Application Number : 19854

Regulatory Info : RX

Registration Country : USA

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

read-more
read-more

01

DR REDDYS

India
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content

RLD : No

TE Code : AB

PENICILLAMINE

Brand Name : PENICILLAMINE

Dosage Form : CAPSULE;ORAL

Dosage Strength : 250MG

Approval Date : 2020-08-04

Application Number : 211867

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Dr Reddy Company Banner

02

BRECKENRIDGE

U.S.A

PENICILLAMINE

Brand Name : PENICILLAMINE

Dosage Form : CAPSULE;ORAL

Dosage Strength : 250MG

Approval Date : 2021-08-23

Application Number : 215409

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Breckenridge Pharmaceutical

03

GRANULES

India
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGranules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Flag India
Digital Content Digital Content

RLD : No

TE Code : AB

PENICILLAMINE

Brand Name : PENICILLAMINE

Dosage Form : CAPSULE;ORAL

Dosage Strength : 250MG

Approval Date : 2020-12-02

Application Number : 211735

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Granules India

04

WATSON LABS INC

Ireland
Vietnam Medi-Pharm Expo
Not Confirmed
arrow

WATSON LABS INC

Ireland
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

PENICILLAMINE

Brand Name : PENICILLAMINE

Dosage Form : CAPSULE;ORAL

Dosage Strength : 250MG

Approval Date : 2019-06-24

Application Number : 210976

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

05

ANI PHARMS

U.S.A
Vietnam Medi-Pharm Expo
Not Confirmed
arrow

ANI PHARMS

U.S.A
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

PENICILLAMINE

Brand Name : LUXZYLA

Dosage Form : CAPSULE;ORAL

Dosage Strength : 250MG

Approval Date : 2019-05-07

Application Number : 209921

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

06

APOTEX

Canada
Vietnam Medi-Pharm Expo
Not Confirmed
arrow

APOTEX

Canada
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

PENICILLAMINE

Brand Name : PENICILLAMINE

Dosage Form : CAPSULE;ORAL

Dosage Strength : 250MG

Approval Date : 2020-04-28

Application Number : 213310

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

07

Vietnam Medi-Pharm Expo
Not Confirmed
arrow
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

PENICILLAMINE

Brand Name : PENICILLAMINE

Dosage Form : CAPSULE;ORAL

Dosage Strength : 250MG

Approval Date : 2021-08-19

Application Number : 213293

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

08

NAVINTA LLC

U.S.A
Vietnam Medi-Pharm Expo
Not Confirmed
arrow

NAVINTA LLC

U.S.A
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

PENICILLAMINE

Brand Name : PENICILLAMINE

Dosage Form : CAPSULE;ORAL

Dosage Strength : 250MG

Approval Date : 2021-10-08

Application Number : 214363

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

09

Vietnam Medi-Pharm Expo
Not Confirmed
arrow
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

PENICILLAMINE

Brand Name : DEPEN

Dosage Form : TABLET;ORAL

Dosage Strength : 250MG

Approval Date : 1982-01-01

Application Number : 19854

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

blank

10

PH HEALTH

Country
Vietnam Medi-Pharm Expo
Not Confirmed
arrow

PH HEALTH

Country
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

PENICILLAMINE

Brand Name : PENICILLAMINE

Dosage Form : TABLET;ORAL

Dosage Strength : 250MG

Approval Date : 2019-12-23

Application Number : 211196

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Empty Capsules

read-more
read-more

Lubricants & Glidants

read-more
read-more

Fillers, Diluents & Binders

read-more
read-more

Coating Systems & Additives

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Emulsifying Agents

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Co-Processed Excipients

read-more
read-more

Granulation

read-more
read-more

Direct Compression

read-more
read-more

Taste Masking

read-more
read-more

Controlled & Modified Release

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Looking for 52-67-5 / Penicillamine API manufacturers, exporters & distributors?

Penicillamine manufacturers, exporters & distributors 1

71

PharmaCompass offers a list of Penicillamine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Penicillamine manufacturer or Penicillamine supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Penicillamine manufacturer or Penicillamine supplier.

API | Excipient name

Penicillamine

Synonyms

D-penicillamine, 52-67-5, Cuprimine, D-(-)-penicillamine, 3-mercapto-d-valine, Depen

Cas Number

52-67-5

Unique Ingredient Identifier (UNII)

GNN1DV99GX

About Penicillamine

3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.

Depamine Manufacturers

A Depamine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Depamine, including repackagers and relabelers. The FDA regulates Depamine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Depamine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Depamine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

Depamine Suppliers

A Depamine supplier is an individual or a company that provides Depamine active pharmaceutical ingredient (API) or Depamine finished formulations upon request. The Depamine suppliers may include Depamine API manufacturers, exporters, distributors and traders.

click here to find a list of Depamine suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

Depamine USDMF

A Depamine DMF (Drug Master File) is a document detailing the whole manufacturing process of Depamine active pharmaceutical ingredient (API) in detail. Different forms of Depamine DMFs exist exist since differing nations have different regulations, such as Depamine USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Depamine DMF submitted to regulatory agencies in the US is known as a USDMF. Depamine USDMF includes data on Depamine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Depamine USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Depamine suppliers with USDMF on PharmaCompass.

Depamine CEP

A Depamine CEP of the European Pharmacopoeia monograph is often referred to as a Depamine Certificate of Suitability (COS). The purpose of a Depamine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Depamine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Depamine to their clients by showing that a Depamine CEP has been issued for it. The manufacturer submits a Depamine CEP (COS) as part of the market authorization procedure, and it takes on the role of a Depamine CEP holder for the record. Additionally, the data presented in the Depamine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Depamine DMF.

A Depamine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Depamine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Depamine suppliers with CEP (COS) on PharmaCompass.

Depamine WC

A Depamine written confirmation (Depamine WC) is an official document issued by a regulatory agency to a Depamine manufacturer, verifying that the manufacturing facility of a Depamine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Depamine APIs or Depamine finished pharmaceutical products to another nation, regulatory agencies frequently require a Depamine WC (written confirmation) as part of the regulatory process.

click here to find a list of Depamine suppliers with Written Confirmation (WC) on PharmaCompass.

Depamine NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Depamine as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Depamine API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Depamine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Depamine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Depamine NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Depamine suppliers with NDC on PharmaCompass.

Depamine GMP

Depamine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Depamine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Depamine GMP manufacturer or Depamine GMP API supplier for your needs.

Depamine CoA

A Depamine CoA (Certificate of Analysis) is a formal document that attests to Depamine's compliance with Depamine specifications and serves as a tool for batch-level quality control.

Depamine CoA mostly includes findings from lab analyses of a specific batch. For each Depamine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Depamine may be tested according to a variety of international standards, such as European Pharmacopoeia (Depamine EP), Depamine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Depamine USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty